A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule

Inclusion Criteria:

• 18-65 years old female patients with cyclomastopathy who signed a written informedconsent.

• The subjects voluntarily entered the clinical observation whom are hospitalizedpatients or outpatients with good compliance.

• They have specific symptoms, such as distending pain of the breast, stabbing pain,dull pain and radiating pain.

• They have specific physical sign, for example, we can touch block gland, granular,nodular or cord like glands and etc..

• Breast ultrasound or molybdenum target show I-III class by Breast Imaging Reportingand Data System.

Exclusion Criteria:

• Women who are pregnant or lactating, and who has the history of periarthritis ofshoulder.

• Excluding breast fibrocellular tumor, breast cancer and other breast diseases.

• Patients with poor self coordination, mentally retarded patients, or havecardiovascular and cerebrovascular disease, severe organic disease, as well as thehematopoietic system disease or mental illness.

• Be judged as over middle degree depression by the Hamilton's depression scale.

• Allergic constitution patients, and people who are allergic to a variety of drugs.

• Any medical history which may interfere with the test results or increase the risk ofpatients according to the investigators.

• Patients who have received treatment of other diseases, and those treatment methodsand targets may have an impact on the indicators of this study.